Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Urinary Tract Obstruction Treatment Devices Market Growth From $1.48 Billion In 2026 To $1.87 Billion By 2030 At A CAGR Of 6%
The urinary tract obstruction treatment devices market has seen robust growth in recent years. This market is expected to expand from $1.4 billion in 2025 to $1.48 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.1%. Historically, this growth has been driven by factors such as the increasing prevalence of kidney stones, an expanding aging demographic, a rise in BPH incidence, the expansion of hospital urology services, and the growing number of catheterization procedures.
The urinary tract obstruction treatment devices market size is projected to exhibit robust expansion over the forthcoming years. This market is set to reach $1.87 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 6.0%. The expansion during the forecast period can be linked to the increasing adoption of laser-based urology, the prevalence of outpatient obstruction treatments, advancements in stent biomaterials, the application of robotic-assisted urology procedures, and efforts to reduce hospital stays. Prominent trends expected in the forecast period include minimally invasive obstruction management, sophisticated laser lithotripsy systems, enhanced ureteral stent designs, advanced endoscopic stone removal techniques, and solutions promoting quicker post-procedure recovery.
Get A Free Sample Report With In-Depth Market Insights:
Urinary Tract Obstruction Treatment Devices Market Opportunity Drivers: What’s Unlocking New Revenue Potential?
The expanding occurrence of kidney disease is anticipated to boost the growth of the urinary tract obstruction treatment devices market. This condition entails impaired kidney function or damage, which hampers the organs’ capacity to remove waste and excess fluids from the blood. The rise in kidney disease cases stems from factors such as an aging demographic, increased incidence of diabetes and hypertension, and detrimental lifestyle choices. Medical intervention is necessary for kidney disease to alleviate kidney pressure and maintain renal function. As the ailment progresses, urinary tract obstructions become more frequent, thereby elevating the demand for devices designed to manage and avert further kidney deterioration. For example, in June 2023, a report from Kidney Research UK, a non-profit organization based in the UK, revealed that around 7.2 million individuals in the UK are currently afflicted with chronic kidney disease, which constitutes over 10% of the populace. Among these, 3.25 million are in advanced stages, while another 3.9 million are in early stages. Projections indicate that by 2033, the population affected by chronic kidney disease will increase to 7.61 million. Consequently, the rising prevalence of kidney disease is set to fuel the expansion of the urinary tract obstruction treatment devices market.
Urinary Tract Obstruction Treatment Devices Market Segment Outlook: Which Categories Are Growing Fastest?
The urinary tract obstruction treatment devices market covered in this report is segmented –
1) By Type: Urinary Catheter, Ureteroscope, Shock Wave Lithotripters, Laser Therapy Systems, Other Types
2) By Application: Cancers, Stones, Benign Prostatic Hyperplasia (BPH), Hydronephrosis
3) By End-User: Hospitals, Ambulatory Surgical Centers, Surgical Centers, Other End-Users
Subsegments:
1) By Urinary Catheter: Foley Urinary Catheters, Intermittent Urinary Catheters, External Urinary Catheters, Supra-Pubic Urinary Catheters, Hydrophilic-Coated Urinary Catheters
2) By Ureteroscope: Rigid Ureteroscopes, Flexible Ureteroscopes, Semi-Rigid Ureteroscopes, Digital Ureteroscopes
3) By Shock Wave Lithotripters: Extracorporeal Shock Wave Lithotripters (ESWL), Pneumatic Shock Wave Lithotripters, Electrohydraulic Shock Wave Lithotripters, Laser-Assisted Shock Wave Lithotripters
4) By Laser Therapy Systems: Holmium Laser Therapy Systems, Thulium Laser Therapy Systems, Diode Laser Therapy Systems, Nd:YAG Laser Therapy Systems
5) By Other Types: Stents For Urinary Tract Obstruction, Percutaneous Nephrostomy Devices, Ureteral Balloon Dilation Catheters, Ureteral Access Sheaths, Urological Drainage Devices
Urinary Tract Obstruction Treatment Devices Market Innovation Trends Shaping Future Development
Leading companies within the urinary tract obstruction treatment devices market are concentrating on minimally invasive, retrievable prostatic implants to deliver reversible, outpatient solutions that alleviate obstruction while preserving tissue and function. A retrievable prostatic stent is a small, implantable nitinol device inserted cystoscopically into the prostatic urethra to restore urine flow without requiring surgery, and it can be taken out or replaced as needed. For example, in April 2025, Rivermark Medical, a US-based medical device company, initiated the pivotal RAPID-III trial for the FloStent system, which is a minimally invasive nitinol prostatic implant designed to relieve lower urinary tract symptoms from benign prostatic hyperplasia (BPH) as a primary, reversible outpatient therapy. The FloStent system aims to provide an option beyond medication and more invasive surgical procedures by gently expanding the prostatic urethra to enhance urinary flow. The study is anticipated to produce essential clinical evidence regarding safety, durability, and improvements in patient quality of life, thereby supporting wider adoption of this implant-based method for BPH management.
Urinary Tract Obstruction Treatment Devices Market Top Companies Driving Competitive Growth
Major companies operating in the urinary tract obstruction treatment devices market are Medtronic Plc, Becton Dickinson and Company, Stryker Corporation, Boston Scientific Corporation, Olympus Corporation, Coloplast Corporation, Smiths Group plc, Bio-Rad Laboratories, Teleflex Incorporated, Paul Hartmann AG, Karl Storz SE & Co. KG, Cook Medical, Hollister Incorporated, Amsino International Inc., Richard Wolf GmbH, Braun Melsungen AG, Angiplast Pvt. Ltd., Mais India Medical Devices Pvt. Ltd., Convatec Inc., VYGON (UK) LTD., United Endoscopy, Advin Health Care, Manish Medi Innovation, MicroPort Urocare (Jiaxing) Co. Ltd., Nikotech Pvt Ltd.
View The Full Urinary Tract Obstruction Treatment Devices Market Report:
Urinary Tract Obstruction Treatment Devices Market Global Footprint: Which Region Leads The Market?
North America was the largest region in the urinary tract obstruction treatment devices market in 2025. The regions covered in the urinary tract obstruction treatment devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model









